Catalyst Wire Dossier Catalyst Wire Dossier

Zuoyu

Levofolinic acid-containing regimen (FOLFOX/FOLFIRI with Zuoyu)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Zuoyu, covering 2023-04-04 to 2023-04-04. Get the full timeline:

Most recent: Clinical Trial Update: FOLFOX/FOLFIRI Containing Levofolinic Acid (Zuoyu ®) in the Treatment of Unresectable or Metastatic Colorectal Cancer [Phase 2]

See pricing